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Surveillance System Overview: National Botulism Surveillance System 
 
Botulism is a rare but serious paralytic illness 
caused by a nerve toxin that is produced by the 
bacterium Clostridium botulinum and 
sometimes by strains of Clostridium butyricum 
and Clostridium baratii. Botulism can be treated 
with an antitoxin that blocks the action of toxin 
circulating in the blood.  
 
Antitoxin for children one year of age and older 
and for adults is available through the Centers 
for Disease Control and Prevention (CDC), the 
Alaska Division of Public Health (ADPH), and the 
California Department of Public Health (CDPH); 
antitoxin for infants is available from CDPH.   
 
Colored transmission electron micrograph of the 
Gram-positive anaerobic bacteria Clostridium 
botulinum
 
Antitoxin can be released through state public health officials for suspected botulism cases and is most 
effective when administered early in a patient’s illness.  State public health officials can reach the CDC 
clinical emergency botulism service for consultation and antitoxin 24/7 at 770-488-7100.  Physicians 
should contact their state health department as soon as they suspect that a patient may have botulism.   
 
For surveillance purposes, CDC categorizes human botulism cases into four transmission categories: 
foodborne, wound, infant, and other.  Foodborne botulism is caused by the consumption of foods 
containing pre-formed botulinum toxin.  Wound botulism is caused by toxin produced in a wound 
infected with Clostridium botulinum.  Infant botulism by definition occurs in persons less than one year 
of age and is caused by consumption of spores of C. botulinum, which then grow and release toxins in 
the intestines.  Cases are classified as “other” if the patient is not an infant, has no history of ingesting a 
suspect food, and has no wounds.  Consistent with the Council of State and Territorial Epidemiologists 
(CSTE) position statements, the “other” category includes botulism in which the route of transmission is 
unknown.  The “other” category also includes iatrogenic botulism, which is caused by an accidental 
overdose of botulinum toxin (i.e., therapeutic injection), and adult intestinal colonization botulism, 
which is very rare but occurs through a mechanism similar to infant botulism. 
 
Since 1973, CDC, in partnership with CSTE, has maintained the National Botulism Surveillance System for 
intensive surveillance for cases of botulism in the United States.  The National Botulism Surveillance 
System collects reports of all laboratory-confirmed botulism cases in the United States and is 
continuously monitored for early detection of outbreaks.  Demographic (e.g., age, sex, race and 
ethnicity), clinical (e.g., transmission category, case-patient outcome), laboratory (e.g., laboratory 
testing method, toxin type), and epidemiologic (e.g., vehicle) data are reported by all 50 states and the 
District of Columbia.  To be confirmed, cases must meet the CSTE case definition 
(http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/botulism_current.htm) of botulism.  Because 
CDC, ADPH, and CDPH are the only sources of botulism antitoxin for cases in the United States, all or 
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almost all recognized cases of botulism are recorded.  However, some cases may not be recognized 
either because of misdiagnosis (2) or because mildly affected persons may not seek medical care (3). 
 
 
Other sources of national-level botulism surveillance data 
 
Several other systems at CDC conduct surveillance for botulism.  The National Notifiable Diseases 
Surveillance System (NNDSS) collects and compiles reports of nationally notifiable infectious diseases, 
including botulism (4).  NNDSS collects data from states on both laboratory-confirmed and probable 
cases of botulism.  NNDSS data is collected from states through several mechanisms, including the 
National Electronic Diseases Surveillance System (NEDSS) which is being developed to integrate both 
epidemiologic and laboratory information; currently laboratory information is not available from NNDSS.  
The Foodborne Disease Outbreak Surveillance System (FDOSS) collects reports of enteric disease 
outbreaks due to foodborne, waterborne, person-to-person, and animal contact transmission from state 
and territorial public health agencies (5).  Additionally, CDC maintains a record of all antitoxin releases 
for cases in categories other than infant botulism.  
 
Overview of Taxonomy 
 
Clostridia spp. are spore-forming, anaerobic, gram-positive bacilli that are commonly found in soil and 
marine sediments.  Under certain conditions spores may germinate into bacilli that can produce toxin.  
These conditions most often occur with improperly home-canned foods; minimally heated chilled food 
that have not been adequately refrigerated; and contaminated wounds.  Clostridium botulinum 
produces seven serologically distinct botulinum toxin types (A–G).  Of these, human botulism is caused 
primarily by toxin types A, B, or E, and rarely by F.   Several related clostridial species can produce 
botulinum toxins as well; toxin type E can be produced by C. butyricum and type F can be produced by C. 
baratii.   
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